Physicochemical Effects of the Major Quassinoids in a Standardized Eurycoma longifolia Extract (Fr 2) on the Bioavailability and Pharmacokinetic Properties, and their Implications for Oral Antimalarial Activity
Authors:
Open Access
- 1 March 2011
- journal article
- research article
- Published by SAGE Publications in Natural Product Communications
- Vol. 6 (3) , 337-41
Abstract
A simple validated LC-UV method for the phytochemical analysis of four bioactive quassinoids, 13α(21)-epoxyeurycomanone (EP), eurycomanone (EN), 13α,21-dihydroeurycomanone (ED) and eurycomanol (EL) in rat plasma following oral (200 mg/kg) and intravenous administration (10 mg/kg) of a standardized extract Fr 2 of Eurycoma longifolia Jack was developed for pharmacokinetic and bioavailability studies. The extract Fr 2 contained 4.0%, 18.5%, 0.7% and 9.5% of EP, EN, ED and EL, respectively. Following intravenous administration, EP displayed a relatively longer biological half-life (t½ = 0.75 ± 0.25 h) due primarily to its lower elimination rate constant (ke) of 0.84 ± 0.26 h−1) when compared with the t½ of 0.35 ± 0.04 h and ke of 2.14 ± 0.27 h−1, respectively of EN. Following oral administration, EP showed a higher Cmax of 1.61± 0.41 μg/mL over that of EN (Cmax = 0.53 ± 0.10 μg/mL). The absolute bioavailability of EP was 9.5-fold higher than that of EN, not because of chemical degradation since both quassinoids were stable at the simulated gastric pH of 1. Instead, the higher log Kow value of EP (-0.43) contributed to greater membrane permeability over that of EN (log Kow = −1.46) at pH 1. In contrast, EL, being in higher concentration in the extract than EP, was not detected in the plasma after oral administration because of substantial degradation by the gastric juices after 2 h. Similarly, ED, being unstable at the acidic pH and together with its low concentration in Fr 2, was not detectable in the rat plasma. In conclusion, upon oral administration of the bioactive standardized extract Fr 2, EP and EN may be the only quassinoids contributing to the overall antimalarial activity; this is worthy of further investigation.Keywords
This publication has 13 references indexed in Scilit:
- Tongkat Ali (Eurycoma longifolia Jack): A review on its ethnobotany and pharmacological importanceFitoterapia, 2010
- 2,3-Dehydro-4α-hydroxylongilactone, a novel quassinoid and two known phenyl propanoids from Eurycoma longifolia JackFood Chemistry, 2009
- Activity of Eurycoma longifolia root extract against Plasmodium falciparum in vitroWiener klinische Wochenschrift, 2009
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Bioavailability and Pharmacokinetic Studies of Eurycomanone fromEurycoma longifoliaPlanta Medica, 2005
- Antiplasmodial studies of Eurycoma longifolia Jack using the lactate dehydrogenase assay of Plasmodium falciparumJournal of Ethnopharmacology, 2004
- Cytotoxic and antimalarial constituents from the roots of Eurycoma longifoliaBioorganic & Medicinal Chemistry, 2004
- Joint Conference of BASEM and BASESBritish Journal of Sports Medicine, 2003
- Absorption prediction from physicochemical parametersPharmaceutical Science & Technology Today, 1999
- Cytotoxic and Antimalarial Constituents of the Roots of Eurycoma longifoliaJournal of Natural Products, 1991